Research Enterprise Newsletter - May 2007: Funding Opportunities
American Lung Association accepting funding proposals
Applications are currently available for the American Lung Association's Nationwide Research Program 2008-2009. The deadline for submitting applications is September 4, 2007. After peer review, applicants will be notified of outcome results in February, 2008. The mission of the American Lung Association is to prevent lung disease and promote lung health. Learn more about the program.
Department of Defense offering Autism Spectrum Disorder Research Funding
The Fiscal Year 2007 (FY07) Defense Appropriations Act provides $7.5 million to the Department of Defense Autism Spectrum Disorder Research Program (ASDRP) to promote innovative research that advances the understanding of Autism Spectrum Disorder and leads to improved treatment outcomes. This program is administered by the US Army Medical Research and Materiel Command through the Office of the Congressionally Directed Medical Research Programs (CDMRP). FY07 ASDRP Program Announcements for proposals in the following mechanisms will be release in the next few weeks:
- Concept Award
- Idea Development Award
- Clinical Partnership Award
Detailed descriptions of each of these mechanisms, evaluation criteria, submission requirements, and deadlines may be obtained in the FY07 ASDRP Program Announcements. Each Program Announcement will be available electronically for downloading from the Grants.gov web site and the CDMRP web site.
Talecris Biotherapeutics' Talents Program Accepting Applications for Research Awards
Talecris Biotherapeutics, Inc. (link), a global biotherapeutic and technology company, has announced that it is accepting applications for its 2007 Talents Research Awards. The Talents New Trials Support program is designed to advance basic and clinical research addressing the use of intravenous immunoglobulin in antibody replacement as well as immune modulation therapies. Talents research grants total approximately $1 million annually and provide a source of funding for research scientists investigating the cause and treatment of immune disorders. Selection of proposals for funding will be based on scientific merit, quality of applicant and research environment, and consistency with the overall program goals. In 2006, the program's inaugural year, Talents grants were made to seven investigators representing major universities, clinics, and institutions in the United States, Canada, and the United Kingdom. The grants funded studies ranging from a multicenter clinical registry to establish the efficacy of IGIV in patients with chronic inflammatory demyelinating polyneuropathy (CIDP) who do not meet normal diagnostic criteria to basic cellular mechanisms by which IGIV mediates immune response. All information about the Talents program, including how to apply, is available on the Talents web site.
